Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Highlights: Location: Spain Languages: Fluent in Russian and English Working hours: 14:00 - 23:00 CET About Fundraise Up We’re Fundraise Up - a global fundraising platform built to make donating to nonprofits fast, seamless, and accessible